EMA
guidance
· 2019-06-28
Bacterial lysate medicines for respiratory conditions to be used only for prevention of recurrent infections
Summary
EU regulatory guidance stating that bacterial lysate medicines for respiratory conditions should be used only for prevention of recurrent infections, not for tr…
Upgrade for the full analysis, importance score, and drug timeline.